The prevalence of allergic rhinitis and atopic markers in obstructive sleep apnea
- DOI
- 10.1016/j.jegh.2016.06.001How to use a DOI?
- Keywords
- Allergic rhinitis; Atopic markers; Atopy; Obstructive sleep apnea
- Abstract
Allergic rhinitis (AR) related inflammation might worsen the severity of obstructive sleep apnea (OSA), however, the relationship between the two disorders remains controversial. Our aim was to determine the prevalence of AR and atopic markers in OSA. This cross-sectional study recruited participants with sleep-related complaints referred to a sleep center from February 2013 to June 2014. The diagnosis of OSA was based on the Berlin questionnaire (BQ) followed by confirmatory polysomnography (PSG). The diagnosis of AR was made via focused history and clinical examination and was confirmed by measuring atopic markers. OSA was diagnosed in 97 out of 157 adults attending the sleep clinic (61.8%). There was a high prevalence of AR (52.6%) among OSA individuals. This was not significantly different from the frequency in the non-OSA individuals (p = 0.5). Elevated total immunoglobulin E (IgE; >100 K/μL), eosinophil count, and positive Phadiatop tests were found in individuals with OSA to be 37.1%, 11.3%, and 41.2%, respectively. Individuals without OSA have shown similar percentages. In our cohort, there was no significant difference in frequency of AR and atopy among participants with OSA compared to those without OSA.
- Copyright
- © 2016 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd.
- Open Access
- This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Download article (PDF)
View full text (HTML)
Cite this article
TY - JOUR AU - Ghadah Gadi AU - Siraj Wali AU - Emad Koshak AU - Mohammad Albar AU - Abdulkareem Fida AU - Muntasir Abdelaziz AU - Khaled Alnoury AU - Nabil Alama PY - 2016 DA - 2016/06/27 TI - The prevalence of allergic rhinitis and atopic markers in obstructive sleep apnea JO - Journal of Epidemiology and Global Health SP - 37 EP - 44 VL - 7 IS - 1 SN - 2210-6014 UR - https://doi.org/10.1016/j.jegh.2016.06.001 DO - 10.1016/j.jegh.2016.06.001 ID - Gadi2016 ER -